{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:03:50Z","timestamp":1790276630715,"version":"4.1.0"},"reference-count":150,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2013,6,10]],"date-time":"2013-06-10T00:00:00Z","timestamp":1370822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Dialysis"],"published-print":{"date-parts":[[2013,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Infection is the second most common cause of death in patients with end\u2010stage renal disease (<jats:styled-content style=\"fixed-case\">ESRD<\/jats:styled-content>), following cardiovascular causes. Immunization is a fairly simple, but underutilized, strategy for prevention of infectious morbidity and mortality in patients with kidney failure. It is imperative for nephrologists and primary care providers to have an understanding of immunization as an essential component of preventive healthcare measures in this high\u2010risk population. Patients with <jats:styled-content style=\"fixed-case\">ESRD<\/jats:styled-content> represent a unique population due to their immunosuppressed state, dialysis\u2010related exposures and suboptimal response to routine vaccines. While the Advisory Committee on Immunization Practices (<jats:styled-content style=\"fixed-case\">ACIP<\/jats:styled-content>) provides guidelines for vaccination of patients with renal disease against Hepatitis B, influenza and pneumococcal disease, the data on immunization against other commonly preventable infectious diseases are lacking. This article reviews the recent evidence on immunization in the <jats:styled-content style=\"fixed-case\">ESRD<\/jats:styled-content> population and synthesizes the related implications for maximizing prevention of infectious diseases in this high\u2010risk population.<\/jats:p>","DOI":"10.1111\/sdi.12101","type":"journal-article","created":{"date-parts":[[2013,6,10]],"date-time":"2013-06-10T09:13:16Z","timestamp":1370855596000},"page":"416-426","source":"Crossref","is-referenced-by-count":41,"title":["Immunization in End\u2010Stage Renal Disease: Opportunity to Improve Outcomes"],"prefix":"10.1111","volume":"26","author":[{"given":"Ritu","family":"Soni","sequence":"first","affiliation":[{"name":"Renal\u2010Electrolyte Division University of Pittsburgh School of Medicine Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Horowitz","sequence":"additional","affiliation":[{"name":"Division of Nephrology University of New Mexico School of Medicine Albuquerque New Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Unruh","sequence":"additional","affiliation":[{"name":"Division of Nephrology University of New Mexico School of Medicine Albuquerque New Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,6,10]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01360307"},{"key":"e_1_2_4_3_1","unstructured":"U S Renal Data System:USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End\u2010Stage Renal Disease in the United States.Bethesda MD:National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases 2012"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2000.00337.x"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000119144.95922.C4"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00414.x"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.120.6.1883"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/089686080802803s34"},{"key":"e_1_2_4_9_1","unstructured":"Centers for Disease Control and Prevention:Pink Book's chapter on Hepatitis B(May 2012)"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxj009"},{"key":"e_1_2_4_11_1","unstructured":"1977 US Department of Health and Human Services Public Health Service CDC Atlanta Georgia Centers for Disease Control and Prevention Hepatitis\u2010control measures for hepatitis B in dialysis centers 12 7"},{"key":"e_1_2_4_12_1","unstructured":"Centers for Disease Control and Prevention.Hemodialysis and viral hepatitis.Available athttp:\/\/www.cdc.gov\/hepatitis\/Settings\/Hemo.htm(last accessed May 17 2013)"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2005.18108.x"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-7-15"},{"issue":"32","key":"e_1_2_4_15_1","first-page":"875","article-title":"Infection Control Requirements for Dialysis Facilities and Clarification Regarding Guidance on Parenteral Medication Vials","volume":"57","author":"CDC","year":"2008","journal-title":"MMWR"},{"issue":"5","key":"e_1_2_4_16_1","article-title":"Recommendations for Preventing Transmission of Infections Among Chronic Hemodialysis Patients","volume":"50","author":"CDC","year":"2001","journal-title":"MMWR"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70312-4"},{"key":"e_1_2_4_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02264.x"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-13-97"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.02.033"},{"key":"e_1_2_4_21_1","doi-asserted-by":"publisher","DOI":"10.5812\/kowsar.1735143X.1771"},{"key":"e_1_2_4_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-011-0043-6"},{"key":"e_1_2_4_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2007.01470.x"},{"key":"e_1_2_4_24_1","first-page":"1953","article-title":"Antibody level after hepatitis\u2010B vaccination in hemodialysis patients: impact of dialysis adequacy, chronic inflammation, local endemicity and nutritional status","volume":"98","author":"Ibrahim S","year":"2006","journal-title":"J Natl Med Assoc"},{"key":"e_1_2_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90036-6"},{"key":"e_1_2_4_26_1","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/ndt\/11.8.1559","article-title":"Response to the hepatitis B virus vaccine in haemodialysis patients: influence of malnutrition and its importance as a risk factor for morbidity and mortality","volume":"11","author":"Fernandez E","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_4_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq094"},{"key":"e_1_2_4_28_1","doi-asserted-by":"publisher","DOI":"10.3109\/0886022X.2011.559300"},{"key":"e_1_2_4_29_1","first-page":"257","article-title":"Immune response to hepatitis B vaccine in haemodialysis patients","volume":"75","author":"Shatat HZ","year":"2000","journal-title":"J Egypt Public Health Assoc"},{"key":"e_1_2_4_30_1","first-page":"113","article-title":"Hepatitis C virus infection decreases the effective antibody response to hepatitis B vaccine in hemodialysis patients","volume":"41","author":"Navarro JF","year":"1994","journal-title":"Clin Nephrol"},{"key":"e_1_2_4_31_1","first-page":"598","article-title":"The evaluation of Tetanus\u2010diphtheria (Td) vaccine impacts on immune response to hepatitis B (HB) vaccine in non\u2010responder dialysis patients","volume":"16","author":"Shahidi S","year":"2011","journal-title":"J Res Med Sci"},{"key":"e_1_2_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.03.038"},{"key":"e_1_2_4_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2008.00936.x"},{"key":"e_1_2_4_34_1","first-page":"798","article-title":"Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection","volume":"14","author":"Sorkhi H","year":"2008","journal-title":"East Mediterr Health J"},{"issue":"4","key":"e_1_2_4_35_1","first-page":"9","article-title":"Recommendations of the Advisory Committee on Immunization Practices (ACIP): Use of Vaccines and Immune Globulins in Persons with Altered Immunocompetence","volume":"42","author":"CDC","year":"1993","journal-title":"MMWR"},{"key":"e_1_2_4_36_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2003.08.019"},{"key":"e_1_2_4_37_1","unstructured":"CDC:Guidelines for Vaccinating Kidney Dialysis Patients and Patients with Chronic Kidney Disease. Summary of ACIP recommendations December2012http:\/\/www.cdc.gov\/dialysis\/PDFs\/Vaccinating_Dialysis_Patients_and_patients_dec2012.pdf"},{"key":"e_1_2_4_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02877.x"},{"key":"e_1_2_4_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq499"},{"key":"e_1_2_4_40_1","first-page":"315","article-title":"The influence of nutritional status, dialysis adequacy, and residual renal function on the response to hepatitis B vaccination in peritoneal dialysis patients","volume":"12","author":"Dacko C","year":"1996","journal-title":"Adv Perit Dial"},{"key":"e_1_2_4_41_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1807-59322011000900009"},{"key":"e_1_2_4_42_1","first-page":"133","article-title":"Does efficient haemodialysis improve the response to hepatitis B virus vaccination?","volume":"126","author":"Kovacic V","year":"2004","journal-title":"Lijec Vjesn"},{"key":"e_1_2_4_43_1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2011.05.2293"},{"key":"e_1_2_4_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2008.01732.x"},{"key":"e_1_2_4_45_1","doi-asserted-by":"publisher","DOI":"10.1159\/000168436"},{"key":"e_1_2_4_46_1","doi-asserted-by":"publisher","DOI":"10.1159\/000188935"},{"key":"e_1_2_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.10.057"},{"key":"e_1_2_4_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2010.01354.x"},{"key":"e_1_2_4_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03002.x"},{"key":"e_1_2_4_50_1","first-page":"536","article-title":"Comparing immune response of intradermal low dose versus intramuscular high dose of hepatitis B vaccination in hemodialysis patients","volume":"16","author":"Momeni A","year":"2011","journal-title":"J Res Med Sci"},{"key":"e_1_2_4_51_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0101-28002011000100006"},{"key":"e_1_2_4_52_1","first-page":"470","article-title":"The evaluation of the effectiveness of multiple dose intradermal hepatitis B re\u2010vaccination in hemodialyzed patients not responding to standard method of immunization","volume":"64","author":"Radziszewski A","year":"2007","journal-title":"Przegl Lek"},{"key":"e_1_2_4_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/12.4.729"},{"key":"e_1_2_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92829-0"},{"key":"e_1_2_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.01.064"},{"key":"e_1_2_4_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03035.x"},{"key":"e_1_2_4_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.07.014"},{"key":"e_1_2_4_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02923.x"},{"key":"e_1_2_4_59_1","first-page":"338","article-title":"Effect of adding levamisole on seroconversion response to hepatitis B virus vaccination in hemodialysis patients: a single\u2010center experience","volume":"5","author":"Sanadgol H","year":"2011","journal-title":"Iran J Kidney Dis"},{"key":"e_1_2_4_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04410.x"},{"key":"e_1_2_4_61_1","first-page":"469","article-title":"Polymethylmethacrylate strengthens antibody response in hemodialysis patients not responding to hepatitis B vaccine: preliminary data","volume":"102","author":"Duranti E","year":"2011","journal-title":"Minerva Med"},{"key":"e_1_2_4_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002725"},{"key":"e_1_2_4_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00689.x"},{"key":"e_1_2_4_64_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.8.2.235"},{"key":"e_1_2_4_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.12.009"},{"key":"e_1_2_4_66_1","first-page":"1","article-title":"Surveillance for acute viral hepatitis \u2010 United States, 2007","volume":"58","author":"Daniels D","year":"2009","journal-title":"MMWR Surveill Summ"},{"key":"e_1_2_4_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20657"},{"key":"e_1_2_4_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a113472"},{"key":"e_1_2_4_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1994.tb01714.x"},{"key":"e_1_2_4_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.10.1825"},{"key":"e_1_2_4_71_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200102150-00023"},{"key":"e_1_2_4_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1708-8305.2006.00106.x"},{"key":"e_1_2_4_73_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2010.04.015"},{"key":"e_1_2_4_74_1","first-page":"1","article-title":"Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007","volume":"56","author":"Fiore AE","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_4_75_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1961.03040220024005"},{"key":"e_1_2_4_76_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199222060-00003"},{"key":"e_1_2_4_77_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-139x.2000.00029.x"},{"key":"e_1_2_4_78_1","first-page":"232","article-title":"Epidemic renal transplant rejection associated with influenza A victoria","volume":"8","author":"Keane WR","year":"1978","journal-title":"Proc Clin Dial Transplant Forum"},{"key":"e_1_2_4_79_1","doi-asserted-by":"publisher","DOI":"10.1159\/000180612"},{"key":"e_1_2_4_80_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.4.5839.520"},{"key":"e_1_2_4_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(09)70175-6"},{"key":"e_1_2_4_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1978.170"},{"key":"e_1_2_4_83_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-79-6-790"},{"key":"e_1_2_4_84_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-197901000-00010"},{"key":"e_1_2_4_85_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.239.24.2562"},{"key":"e_1_2_4_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01644539"},{"key":"e_1_2_4_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00126-2"},{"key":"e_1_2_4_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(87)90008-9"},{"key":"e_1_2_4_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2003.11.046"},{"key":"e_1_2_4_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.10.047"},{"key":"e_1_2_4_91_1","doi-asserted-by":"publisher","DOI":"10.1159\/000045713"},{"key":"e_1_2_4_92_1","doi-asserted-by":"publisher","DOI":"10.1159\/000182898"},{"key":"e_1_2_4_93_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02160311"},{"key":"e_1_2_4_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.023"},{"key":"e_1_2_4_95_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01963779"},{"key":"e_1_2_4_96_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00787.x"},{"key":"e_1_2_4_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.05.016"},{"key":"e_1_2_4_98_1","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9071(200104)63:4<293::AID-JMV1004>3.0.CO;2-C"},{"key":"e_1_2_4_99_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.294.6568.348"},{"key":"e_1_2_4_100_1","doi-asserted-by":"publisher","DOI":"10.1086\/599790"},{"key":"e_1_2_4_101_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2010.11.031"},{"key":"e_1_2_4_102_1","unstructured":"CDC:Active Bacterial Core surveillance report Emerging Infections Program Network Streptococcus pneumoniae 2010.Atlanta GA:US Department of Health and Human Services CDC 2011. Available athttp:\/\/www.cdc.gov\/abcs\/reports-findings\/survreports\/spneu10.html(last accessed May 17 2013)"},{"key":"e_1_2_4_103_1","first-page":"S143","article-title":"Long\u2010term complications of dialysis: infection","volume":"41","author":"Khan IH","year":"1993","journal-title":"Kidney Int Suppl"},{"key":"e_1_2_4_104_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.08.032"},{"key":"e_1_2_4_105_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0894-0959.2004.17339.x"},{"key":"e_1_2_4_106_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05980809"},{"key":"e_1_2_4_107_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.12.038"},{"key":"e_1_2_4_108_1","first-page":"369","article-title":"Pneumococcal capsular polysaccharide vaccination in adult chronic hemodialysis patients","volume":"26","author":"Katz LA","year":"1980","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"e_1_2_4_109_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1985.182"},{"key":"e_1_2_4_110_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-182-42367"},{"key":"e_1_2_4_111_1","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1001\/archinte.1986.00360200116019","article-title":"Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine","volume":"146","author":"Linnemann CJ","year":"1986","journal-title":"Arch Intern Med"},{"key":"e_1_2_4_112_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.ndt.a027313"},{"key":"e_1_2_4_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70435-3"},{"key":"e_1_2_4_114_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm851"},{"key":"e_1_2_4_115_1","first-page":"43","article-title":"Immunogenicity of pneumococcal vaccination in renal transplant recipients and hemodialysis patients: a comparative controlled trial","volume":"13","author":"Pourfarziani V","year":"2008","journal-title":"Ann Transplant"},{"key":"e_1_2_4_116_1","doi-asserted-by":"publisher","DOI":"10.1159\/000079883"},{"key":"e_1_2_4_117_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2012.04.018"},{"key":"e_1_2_4_118_1","unstructured":"FDA:Vaccines and Related Biological Products Advisory Committee (VRBPAC) adult indication briefing document: Prevnar 13.Silver Spring MD:US Department of Health and Human Services Food and Drug Administration 2011"},{"issue":"2","key":"e_1_2_4_119_1","first-page":"22","article-title":"The evaluation of renal transplant candidates: clinical practice guidelines. American Society of Transplantation","volume":"1","author":"Kasiske B","year":"2001","journal-title":"Am J Transplant"},{"key":"e_1_2_4_120_1","unstructured":"FDA:FDA expands use of Prevnar 13 vaccine for people ages 50 and older.Silver Spring MD:US Department of Health and Human Services Food and Drug Administration 2011. Available athttp:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/ucm285431.htm. Accessed May 17 2013"},{"issue":"40","key":"e_1_2_4_121_1","first-page":"816","article-title":"Centers for Disease Control and Prevention. Use of 13\u2010valent pneumococcal conjugate vaccine and 23\u2010valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"e_1_2_4_122_1","first-page":"365","article-title":"Tetanus surveillance \u2014 United States, 2001\u2010. 2008","volume":"60","author":"CDC","year":"2011","journal-title":"MMWR"},{"key":"e_1_2_4_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00334-X"},{"key":"e_1_2_4_124_1","doi-asserted-by":"publisher","DOI":"10.3844\/ajisp.2009.108.112"},{"key":"e_1_2_4_125_1","first-page":"45","article-title":"Antitetanus toxoid antibody titer of chronic hemodialysis patients in Iran","volume":"5","author":"Sagheb MM","year":"2008","journal-title":"Iran J Immunol"},{"key":"e_1_2_4_126_1","first-page":"31","article-title":"Tetanus antitoxin levels and cutaneous anergy in hemodialysis patients in two university hospitals in Iran","volume":"1","author":"Aminzadeh Z","year":"2006","journal-title":"Iranian Journal of Clinical Infectious Diseases"},{"key":"e_1_2_4_127_1","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.29223"},{"key":"e_1_2_4_128_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.ndt.a092136"},{"key":"e_1_2_4_129_1","doi-asserted-by":"publisher","DOI":"10.1080\/08860220701573533"},{"key":"e_1_2_4_130_1","doi-asserted-by":"publisher","DOI":"10.3109\/08860220903268353"},{"key":"e_1_2_4_131_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010077622172"},{"issue":"25","key":"e_1_2_4_132_1","first-page":"468","article-title":"Advisory Committee on Immunization Practices (ACIP): Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR"},{"key":"e_1_2_4_133_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200202270-00023"},{"key":"e_1_2_4_134_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39206.571042.AE"},{"key":"e_1_2_4_135_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.822"},{"key":"e_1_2_4_136_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-154-5-201103010-01003"},{"key":"e_1_2_4_137_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2012.03.018"},{"key":"e_1_2_4_138_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2011.10.049"},{"key":"e_1_2_4_139_1","doi-asserted-by":"publisher","DOI":"10.1159\/000339004"},{"key":"e_1_2_4_140_1","first-page":"CD008858","article-title":"Vaccines for preventing herpes zoster in older adults","volume":"10","author":"Gagliardi AM","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_4_141_1","first-page":"211","article-title":"United States, 2012","volume":"156","author":"Recommended adult immunization schedule","year":"2012","journal-title":"Ann Intern Med"},{"key":"e_1_2_4_142_1","unstructured":"Merck:Highlights of Prescribing Informations. Available athttp:\/\/www.merck.com\/product\/usa\/pi_circulars\/z\/zostavax\/zostavax_pi2.pdf(last accessed December 31 2012)"},{"key":"e_1_2_4_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.03.031"},{"key":"e_1_2_4_144_1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1681\/ASN.V72247","article-title":"Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide\u2010Pseudomonas aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysis","volume":"7","author":"Welch PG","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_4_145_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011297"},{"key":"e_1_2_4_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.06.043"},{"key":"e_1_2_4_147_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00034-12"},{"key":"e_1_2_4_148_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02917.x"},{"key":"e_1_2_4_149_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-010-1354-5"},{"key":"e_1_2_4_150_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneph1003"},{"issue":"40","key":"e_1_2_4_151_1","first-page":"816","article-title":"Use of 13\u2010Valent Pneumococcal Conjugate Vaccine and 23\u2010Valent Pneumococcal Polysaccharide Vaccine for Adults with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR"}],"container-title":["Seminars in Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fsdi.12101","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fsdi.12101","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/sdi.12101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T14:36:55Z","timestamp":1696171015000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/sdi.12101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,10]]},"references-count":150,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.1111\/sdi.12101"],"URL":"https:\/\/doi.org\/10.1111\/sdi.12101","archive":["Portico"],"relation":{},"ISSN":["0894-0959","1525-139X"],"issn-type":[{"value":"0894-0959","type":"print"},{"value":"1525-139X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,10]]}}}